NasdaqGS:TECHLife Sciences
Will New 3D Multiomic Workflow and Leo System Expansion Change Bio-Techne's (TECH) Narrative?
In December 2025, Bio-Techne’s Lunaphore unit and the Wyss Center for Bio and Neuroengineering in Geneva announced a collaboration to automate simultaneous RNA and protein detection in intact 3D specimens, while the company also expanded the launch of its next-generation Leo System featuring dual-channel fluorescence and high-throughput protein analysis.
Together, these advances extend Bio-Techne’s spatial and proteomic platforms from 2D into true 3D multiomic workflows, potentially...